Source:http://linkedlifedata.com/resource/pubmed/id/18547969
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2008-6-12
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
1423-0240
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
31
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
300-2
|
| pubmed:meshHeading |
pubmed-meshheading:18547969-Antineoplastic Agents, Alkylating,
pubmed-meshheading:18547969-Brain Neoplasms,
pubmed-meshheading:18547969-Chemotherapy, Adjuvant,
pubmed-meshheading:18547969-Dacarbazine,
pubmed-meshheading:18547969-Glioma,
pubmed-meshheading:18547969-Humans,
pubmed-meshheading:18547969-Treatment Outcome
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
Management of malignant glioma--quo vadis?
|
| pubmed:publicationType |
Editorial,
Comment,
Introductory Journal Article
|